vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Evercore Inc. (EVR). Click either name above to swap in a different company.
Evercore Inc. is the larger business by last-quarter revenue ($1.4B vs $962.7M, roughly 1.5× APTARGROUP, INC.). Evercore Inc. runs the higher net margin — 23.0% vs 7.7%, a 15.3% gap on every dollar of revenue. On growth, Evercore Inc. posted the faster year-over-year revenue change (100.3% vs 13.5%). Over the past eight quarters, Evercore Inc.'s revenue compounded faster (42.2% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding.
ATR vs EVR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $1.4B |
| Net Profit | $74.3M | $322.7M |
| Gross Margin | — | — |
| Operating Margin | 11.0% | — |
| Net Margin | 7.7% | 23.0% |
| Revenue YoY | 13.5% | 100.3% |
| Net Profit YoY | -26.4% | 106.1% |
| EPS (diluted) | $1.13 | $7.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.4B | ||
| Q4 25 | $962.7M | $1.3B | ||
| Q3 25 | $961.1M | $1.0B | ||
| Q2 25 | $966.0M | $838.0M | ||
| Q1 25 | $887.3M | $699.0M | ||
| Q4 24 | $848.1M | $979.5M | ||
| Q3 24 | $909.3M | $738.4M | ||
| Q2 24 | $910.1M | $693.4M |
| Q1 26 | — | $322.7M | ||
| Q4 25 | $74.3M | $204.0M | ||
| Q3 25 | $127.9M | $144.6M | ||
| Q2 25 | $111.7M | $97.2M | ||
| Q1 25 | $78.8M | $146.2M | ||
| Q4 24 | $100.9M | $140.4M | ||
| Q3 24 | $100.0M | $78.4M | ||
| Q2 24 | $90.5M | $73.8M |
| Q1 26 | — | — | ||
| Q4 25 | 11.0% | 24.2% | ||
| Q3 25 | 14.2% | 20.8% | ||
| Q2 25 | 14.9% | 18.0% | ||
| Q1 25 | 12.8% | 16.0% | ||
| Q4 24 | 14.2% | 21.8% | ||
| Q3 24 | 15.2% | 16.7% | ||
| Q2 24 | 13.8% | 15.9% |
| Q1 26 | — | 23.0% | ||
| Q4 25 | 7.7% | 15.7% | ||
| Q3 25 | 13.3% | 13.8% | ||
| Q2 25 | 11.6% | 11.6% | ||
| Q1 25 | 8.9% | 20.9% | ||
| Q4 24 | 11.9% | 14.3% | ||
| Q3 24 | 11.0% | 10.6% | ||
| Q2 24 | 9.9% | 10.6% |
| Q1 26 | — | $7.20 | ||
| Q4 25 | $1.13 | $4.80 | ||
| Q3 25 | $1.92 | $3.41 | ||
| Q2 25 | $1.67 | $2.36 | ||
| Q1 25 | $1.17 | $3.48 | ||
| Q4 24 | $1.48 | $3.32 | ||
| Q3 24 | $1.48 | $1.86 | ||
| Q2 24 | $1.34 | $1.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | — |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | — |
| Total Assets | $5.3B | — |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $409.5M | $3.0B | ||
| Q3 25 | $264.8M | $2.4B | ||
| Q2 25 | $169.8M | $1.7B | ||
| Q1 25 | $136.8M | $1.4B | ||
| Q4 24 | $226.2M | $2.4B | ||
| Q3 24 | $327.9M | $1.8B | ||
| Q2 24 | $223.9M | $1.7B |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.7B | $2.0B | ||
| Q3 25 | $2.8B | $1.8B | ||
| Q2 25 | $2.7B | $1.7B | ||
| Q1 25 | $2.5B | $1.5B | ||
| Q4 24 | $2.5B | $1.7B | ||
| Q3 24 | $2.5B | $1.6B | ||
| Q2 24 | $2.4B | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | $5.3B | $5.4B | ||
| Q3 25 | $5.1B | $4.4B | ||
| Q2 25 | $4.9B | $3.7B | ||
| Q1 25 | $4.5B | $3.3B | ||
| Q4 24 | $4.4B | $4.2B | ||
| Q3 24 | $4.6B | $3.6B | ||
| Q2 24 | $4.5B | $3.3B |
| Q1 26 | — | — | ||
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | — |
| Free Cash FlowOCF − Capex | $96.9M | — |
| FCF MarginFCF / Revenue | 10.1% | — |
| Capex IntensityCapex / Revenue | 9.0% | — |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $183.7M | $807.5M | ||
| Q3 25 | $177.6M | $560.9M | ||
| Q2 25 | $126.0M | $437.7M | ||
| Q1 25 | $82.7M | $-549.7M | ||
| Q4 24 | $178.2M | $686.4M | ||
| Q3 24 | $229.3M | $234.5M | ||
| Q2 24 | $143.6M | $348.5M |
| Q1 26 | — | — | ||
| Q4 25 | $96.9M | $798.6M | ||
| Q3 25 | $114.3M | $541.5M | ||
| Q2 25 | $62.5M | $411.7M | ||
| Q1 25 | $25.9M | $-569.3M | ||
| Q4 24 | $112.2M | $673.1M | ||
| Q3 24 | $162.7M | $226.6M | ||
| Q2 24 | $75.4M | $340.7M |
| Q1 26 | — | — | ||
| Q4 25 | 10.1% | 61.6% | ||
| Q3 25 | 11.9% | 51.8% | ||
| Q2 25 | 6.5% | 49.1% | ||
| Q1 25 | 2.9% | -81.4% | ||
| Q4 24 | 13.2% | 68.7% | ||
| Q3 24 | 17.9% | 30.7% | ||
| Q2 24 | 8.3% | 49.1% |
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | 0.7% | ||
| Q3 25 | 6.6% | 1.9% | ||
| Q2 25 | 6.6% | 3.1% | ||
| Q1 25 | 6.4% | 2.8% | ||
| Q4 24 | 7.8% | 1.4% | ||
| Q3 24 | 7.3% | 1.1% | ||
| Q2 24 | 7.5% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 2.47× | 3.96× | ||
| Q3 25 | 1.39× | 3.88× | ||
| Q2 25 | 1.13× | 4.50× | ||
| Q1 25 | 1.05× | -3.76× | ||
| Q4 24 | 1.77× | 4.89× | ||
| Q3 24 | 2.29× | 2.99× | ||
| Q2 24 | 1.59× | 4.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
EVR
| Advisory Fees (1) | $1.2B | 89% |
| Commissions and Related Revenue | $62.7M | 4% |
| Underwriting Fees | $55.1M | 4% |
| Asset Management and Administration Fees (2) | $23.7M | 2% |
| Other Revenue, net | $15.4M | 1% |
